Drug
Crofelemer clinical trials
- studies test it
- 11
- open now
- 0
- in phase 3
- 4
- first study started
- 2004
How studies write it
Studies that test it under each name
Name
Brand
Studies by the year they started
9 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 4
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 4
Bausch Health Americas, Inc. (4) · Shaman Pharmaceuticals (2) · Jessica Sosio (1) · The University of Texas Health Science Center, Houston (1) · Napo Pharmaceuticals, Inc. (1) · Sandra Swain (1) · Beth Israel Deaconess Medical Center (1)
Studies
Open first, then newest update. How each study uses crofelemer is read from its arms, and is right about nine times in ten.
Testing it · 11
- Open-Label Pilot Study With Crofelemer in Patients With Short Bowel SyndromeActive, not recruitingEarly Phase 1Jessica SosioNCT06326645Written as Crofelemer Oral Product
- Crofelemer for Functional DiarrheaTerminatedPhase 4Beth Israel Deaconess Medical CenterNCT04486326Written as Crofelemer
- Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV PatientsCompletedPhase 4The University of Texas Health Science Center, HoustonNCT03898856Written as Crofelemer
- Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer TherapyCompletedPhase 3Napo Pharmaceuticals, Inc.NCT04538625Written as Crofelemer 125 MG [Mytesi]
- Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer PatientsCompletedPhase 2Sandra SwainNCT02910219Written as Crofelemer
- Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated DiarrheaCompletedPhase 3Bausch Health Americas, Inc.NCT00547898Written as Crofelemer 125 mg
- Safety and Tolerability of Crofelemer for HIV-Associated DiarrheaCompletedPhase 3Bausch Health Americas, Inc.NCT01374490Written as Crofelemer
- Diarrhea Predominant Irritable Bowel Syndrome in FemalesCompletedPhase 2Bausch Health Americas, Inc.NCT00461526Written as crofelemer
- A Study of Crofelemer to Treat Diarrhea Irritable Bowel SyndromeCompletedPhase 2Bausch Health Americas, Inc.NCT00101725Written as crofelemer
- SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With AcyclovirCompletedNot applicableShaman PharmaceuticalsNCT00002310Written as Crofelemer
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) PatientsCompletedPhase 3Shaman PharmaceuticalsNCT00002408Written as Crofelemer
Given in every arm · 1 — crofelemer is usual care beside what is tested
Codes
What other systems call crofelemer · ClinicalTrials.gg INT005564
- MeSH (NLM) C546704crofelemerConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) PY79D6C8RXCROFELEMERConfirmed FDA, NLM, Wikidata
- RxNorm 1364449Confirmed FDA, Wikidata
- Wikidata Q5187464crofelemerConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C125392CrofelemerConfirmed FDA, Wikidata
- DrugBank DB04941One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C546704 | crofelemer | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | PY79D6C8RX | CROFELEMER | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1364449 | — | Confirmed FDA, Wikidata |
| Wikidata | Q5187464 | crofelemer | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C125392 | Crofelemer | Confirmed FDA, Wikidata |
| DrugBank | DB04941 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.